Home > National Drug Code (NDC) > Dock/Sorrel Mixture

Dock/Sorrel Mixture - 49288-0183-5 - (Dock/Sorrel Mixture)

Alphabetical Index


Drug Information of Dock/Sorrel Mixture

Product NDC: 49288-0183
Proprietary Name: Dock/Sorrel Mixture
Non Proprietary Name: Dock/Sorrel Mixture
Active Ingredient(s): .025; .025    g/mL; g/mL & nbsp;   Dock/Sorrel Mixture
Administration Route(s): INTRADERMAL; SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Dock/Sorrel Mixture

Product NDC: 49288-0183
Labeler Name: Antigen Laboratories, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA102223
Marketing Category: BLA
Start Marketing Date: 20070716

Package Information of Dock/Sorrel Mixture

Package NDC: 49288-0183-5
Package Description: 50 mL in 1 VIAL, MULTI-DOSE (49288-0183-5)

NDC Information of Dock/Sorrel Mixture

NDC Code 49288-0183-5
Proprietary Name Dock/Sorrel Mixture
Package Description 50 mL in 1 VIAL, MULTI-DOSE (49288-0183-5)
Product NDC 49288-0183
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Dock/Sorrel Mixture
Dosage Form Name INJECTION, SOLUTION
Route Name INTRADERMAL; SUBCUTANEOUS
Start Marketing Date 20070716
Marketing Category Name BLA
Labeler Name Antigen Laboratories, Inc.
Substance Name RUMEX ACETOSELLA POLLEN; RUMEX CRISPUS POLLEN
Strength Number .025; .025
Strength Unit g/mL; g/mL
Pharmaceutical Classes Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Increased Histamine Release [PE],Allergens [Chemical/Ingredient]

Complete Information of Dock/Sorrel Mixture


General Information